469 related articles for article (PubMed ID: 34742744)
1. Neuronal and cardiac toxicity of pharmacological compounds identified through transcriptomic analysis of human pluripotent stem cell-derived embryoid bodies.
Konala VBR; Nandakumar S; Surendran H; Datar S; Bhonde R; Pal R
Toxicol Appl Pharmacol; 2021 Dec; 433():115792. PubMed ID: 34742744
[TBL] [Abstract][Full Text] [Related]
2. A novel human pluripotent stem cell-based assay to predict developmental toxicity.
Lauschke K; Rosenmai AK; Meiser I; Neubauer JC; Schmidt K; Rasmussen MA; Holst B; Taxvig C; Emnéus JK; Vinggaard AM
Arch Toxicol; 2020 Nov; 94(11):3831-3846. PubMed ID: 32700165
[TBL] [Abstract][Full Text] [Related]
3. Optimized conditions for the supplementation of human-induced pluripotent stem cell cultures with a GSK-3 inhibitor during embryoid body formation with the aim of inducing differentiation into mesodermal and cardiac lineage.
Yoda K; Ohnuki Y; Masui S; Kurosawa H
J Biosci Bioeng; 2020 Mar; 129(3):371-378. PubMed ID: 31615734
[TBL] [Abstract][Full Text] [Related]
4. Morphological observation of embryoid bodies completes the in vitro evaluation of nanomaterial embryotoxicity in the embryonic stem cell test (EST).
Corradi S; Dakou E; Yadav A; Thomassen LC; Kirsch-Volders M; Leyns L
Toxicol In Vitro; 2015 Oct; 29(7):1587-96. PubMed ID: 26093180
[TBL] [Abstract][Full Text] [Related]
5. An automated and high-throughput-screening compatible pluripotent stem cell-based test platform for developmental and reproductive toxicity assessment of small molecule compounds.
Witt G; Keminer O; Leu J; Tandon R; Meiser I; Willing A; Winschel I; Abt JC; Brändl B; Sébastien I; Friese MA; Müller FJ; Neubauer JC; Claussen C; Zimmermann H; Gribbon P; Pless O
Cell Biol Toxicol; 2021 Apr; 37(2):229-243. PubMed ID: 32564278
[TBL] [Abstract][Full Text] [Related]
6. A scale out approach towards neural induction of human induced pluripotent stem cells for neurodevelopmental toxicity studies.
Miranda CC; Fernandes TG; Pinto SN; Prieto M; Diogo MM; Cabral JMS
Toxicol Lett; 2018 Sep; 294():51-60. PubMed ID: 29775723
[TBL] [Abstract][Full Text] [Related]
7. Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells.
Mayshar Y; Yanuka O; Benvenisty N
J Cell Mol Med; 2011 Jun; 15(6):1393-401. PubMed ID: 20561110
[TBL] [Abstract][Full Text] [Related]
8. Agathisflavone enhances retinoic acid-induced neurogenesis and its receptors α and β in pluripotent stem cells.
Paulsen BS; Souza CS; Chicaybam L; Bonamino MH; Bahia M; Costa SL; Borges HL; Rehen SK
Stem Cells Dev; 2011 Oct; 20(10):1711-21. PubMed ID: 21281018
[TBL] [Abstract][Full Text] [Related]
9. Early gene expression changes during embryonic stem cell differentiation into cardiomyocytes and their modulation by monobutyl phthalate.
van Dartel DA; Pennings JL; Hendriksen PJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Apr; 27(2):93-102. PubMed ID: 19162170
[TBL] [Abstract][Full Text] [Related]
10. An in vitro embryotoxicity assay based on the disturbance of the differentiation of murine embryonic stem cells into endothelial cells. II. Testing of compounds.
Festag M; Viertel B; Steinberg P; Sehner C
Toxicol In Vitro; 2007 Dec; 21(8):1631-40. PubMed ID: 17719739
[TBL] [Abstract][Full Text] [Related]
11. An Evaluation of Human Induced Pluripotent Stem Cells to Test for Cardiac Developmental Toxicity.
Walker LM; Sparks NRL; Puig-Sanvicens V; Rodrigues B; Zur Nieden NI
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360880
[TBL] [Abstract][Full Text] [Related]
12. Focus on germ-layer markers: A human stem cell-based model for in vitro teratogenicity testing.
Jaklin M; Zhang JD; Barrow P; Ebeling M; Clemann N; Leist M; Kustermann S
Reprod Toxicol; 2020 Dec; 98():286-298. PubMed ID: 33147516
[TBL] [Abstract][Full Text] [Related]
13. PRC1 catalytic unit RING1B regulates early neural differentiation of human pluripotent stem cells.
Desai D; Khanna A; Pethe P
Exp Cell Res; 2020 Nov; 396(1):112294. PubMed ID: 32971117
[TBL] [Abstract][Full Text] [Related]
14. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.
Burridge PW; Thompson S; Millrod MA; Weinberg S; Yuan X; Peters A; Mahairaki V; Koliatsos VE; Tung L; Zambidis ET
PLoS One; 2011 Apr; 6(4):e18293. PubMed ID: 21494607
[TBL] [Abstract][Full Text] [Related]
15. Advanced developmental toxicity test method based on embryoid body's area.
Kang HY; Choi YK; Jo NR; Lee JH; Ahn C; Ahn IY; Kim TS; Kim KS; Choi KC; Lee JK; Lee SD; Jeung EB
Reprod Toxicol; 2017 Sep; 72():74-85. PubMed ID: 28673813
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic characterization of C57BL/6 mouse embryonic stem cell differentiation and its modulation by developmental toxicants.
Gao X; Yourick JJ; Sprando RL
PLoS One; 2014; 9(9):e108510. PubMed ID: 25247782
[TBL] [Abstract][Full Text] [Related]
17. Embryotoxicity hazard assessment of methylmercury and chromium using embryonic stem cells.
Stummann TC; Hareng L; Bremer S
Toxicology; 2007 Dec; 242(1-3):130-43. PubMed ID: 17980949
[TBL] [Abstract][Full Text] [Related]
18. Detection of thalidomide embryotoxicity by in vitro embryotoxicity testing based on human iPS cells.
Aikawa N; Kunisato A; Nagao K; Kusaka H; Takaba K; Ohgami K
J Pharmacol Sci; 2014; 124(2):201-7. PubMed ID: 24451995
[TBL] [Abstract][Full Text] [Related]
19. Adverse effect of valproic acid on an in vitro gastrulation model entails activation of retinoic acid signaling.
Li AS; Marikawa Y
Reprod Toxicol; 2016 Dec; 66():68-83. PubMed ID: 27693483
[TBL] [Abstract][Full Text] [Related]
20. Effects of acute ethanol treatment on NCCIT cells and NCCIT cell-derived embryoid bodies (EBs).
Jung KH; Das ND; Park JH; Lee HT; Choi MR; Chung MK; Park KS; Jung MH; Lee BC; Choi IG; Chai YG
Toxicol In Vitro; 2010 Sep; 24(6):1696-704. PubMed ID: 20621659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
